Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease
JF Dorval, T Anderson, J Buithieu, S Chan… - The American journal of …, 2005 - Elsevier
The effects of combined atorvastatin and amlodipine on blood pressure (BP) and low-
density lipoprotein (LDL) cholesterol levels were investigated in 134 patients with …
density lipoprotein (LDL) cholesterol levels were investigated in 134 patients with …
P-413: The efficacy and safety of fixed-dose combinations of amlodipine and atorvastatin in the treatment of patients with concomitant hypertension and dyslipidemia
RA Preston, P Harvey, O Herfert… - American Journal of …, 2004 - search.proquest.com
Hypertension (HTN) and dyslipidemia (DYS) commonly coexist. Patients with concurrent
HTN and DYS are at high risk of cardiovascular disease, yet most patients do not achieve …
HTN and DYS are at high risk of cardiovascular disease, yet most patients do not achieve …
A randomized, placebo‐controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 …
RA Preston, P Harvey, O Herfert… - The Journal of …, 2007 - Wiley Online Library
Guidelines stress the importance of the simultaneous management of multiple
cardiovascular risk factors. This can in part be achieved by coadministration of lipid …
cardiovascular risk factors. This can in part be achieved by coadministration of lipid …
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial
FH Messerli, GL Bakris, RD Ferrera… - The Journal of …, 2006 - Wiley Online Library
The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …
Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia
K McKeage, MAA Siddiqui - American journal of cardiovascular drugs, 2008 - Springer
Amlodipine/atorvastatin (Caduet®) is a once-daily fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease
MP Curran - Drugs, 2010 - Springer
Amlodipine/atorvastatin (Caduet®) is a single-tablet, fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease
DG Karalis, AM Ross, RM Vacari, H Zarren… - The American journal of …, 2002 - Elsevier
The efficacy and safety of atorvastatin 10 mg versus simvastatin 20 mg and atorvastatin 80
mg versus simvastatin 80 mg was determined in a 6-week, prospective, randomized, open …
mg versus simvastatin 80 mg was determined in a 6-week, prospective, randomized, open …
Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
M Devabhaktuni, S Bangalore - Vascular health and risk …, 2009 - Taylor & Francis
Hypertension and dyslipidemia are two of the most commonly co-occurring cardiovascular
risk factors which together cause an increase in coronary heart disease-related events that …
risk factors which together cause an increase in coronary heart disease-related events that …
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia
M Davidson, J McKenney, E Stein, H Schrott… - American Journal of …, 1997 - ajconline.org
This double-blind study to evaluate long-term efficacy and safety of atorvastatin was
performed in 31 community-and university-based research centers in the USA to directly …
performed in 31 community-and university-based research centers in the USA to directly …
Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients
G Derosa, P Maffioli - Expert Review of Cardiovascular Therapy, 2010 - Taylor & Francis
Therapies that lower blood pressure or lipid levels slow the progression of atherosclerosis,
and reduce morbidity and mortality in patients with hypertension or atherosclerotic disease …
and reduce morbidity and mortality in patients with hypertension or atherosclerotic disease …